Wikisage, the free encyclopedia of the second generation, is digital heritage
Hyperhomocysteinemia: Difference between revisions
Jump to navigation
Jump to search
(punMED) |
(2nd) |
||
| Line 3: | Line 3: | ||
Numata et al.2015 | Numata et al.2015 | ||
[http://www.biomedcentral.com/1471-2350/16/54 Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis] BMC Mol.Genetics ;16:54. doi: 10.1186/s12881-015-0197-7. | *[http://www.biomedcentral.com/1471-2350/16/54 Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis] BMC Mol.Genetics ;16:54. doi: 10.1186/s12881-015-0197-7. | ||
*Arroyo Jossue et al 2015 | |||
[http://www.scielo.cl/pdf/rmc/v143n5/art02.pdf La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients)] rev Med Chile: 143: 562-568 | |||
[[nl:Hyperhomocysteïnemie]] | [[nl:Hyperhomocysteïnemie]] | ||
Revision as of 23:18, 28 July 2015
Hyperhomocysteinemia or hyperhomocysteinaemia is a medical condition characterized by an abnormally high level of homocysteine in the blood, conventionally described as above 15 µmol/L
Disease classification WHO
hyperhomocisteinaemia E 72.1
Numata et al.2015
- Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis BMC Mol.Genetics ;16:54. doi: 10.1186/s12881-015-0197-7.
- Arroyo Jossue et al 2015
La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients) rev Med Chile: 143: 562-568